AlfaKinetic
by Anervea
LandscapeMonitorCompareProfileAsk
principle

Nothing is shown without a source. When the data can’t answer, the product says so.

LB Pharmaceuticals
tenant
person

Takehisa Matsumaru

as of 2026-07-01
Monitor thisAsk about this
at a glance
Roles: Study Director
Synthesized from structured facts only — each point cited above.

Profile

Affiliation
Otsuka Pharmaceutical Co., Ltd.
Roles
Study Director
Trial investigator
no

Trials led

3
A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses
NCT04118127Phase 1Completed
Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
NCT06036108Phase 1Completed
A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia
NCT05119894Phase 1Withdrawn

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
STUDY_DIRECTOR
A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses
trial
Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
trial
A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia
trial